Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring

被引：1
|
作者：
Prizant, Hen
Shamshoian, John
Abel, John
Beck, Andrew
Chambre, Laura
Hennek, Stephanie
Koeppen, Hartmut
Ruderman, Daniel
Das Thakur, Meghna
Montalto, Michael
Trotter, Benjamin
Wapinski, Ilan
Zou, Wei
Srivastava, Minu K.
Giltnane, Jennifer
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5358
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Assessment of concordance among 22C3, SP263, and SP142 immunohistochemistry assay for PD-L1 expression in non-small cell lung cancer.
    Jung, Chi Young
    Kim, Eun Jin
    Sung, Woo Jung
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 41 - 42
  • [22] Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software
    Naso, Julia R.
    Povshedna, Tetiana
    Wang, Gang
    Banyi, Norbert
    MacAulay, Calum
    Ionescu, Diana N.
    Zhou, Chen
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [23] Immunohistochemical (IHC) scoring of programmed death-ligand 1 (PD-L1) protein expression in non-small cell lung cancer (NSCLC) using an automated digital pathology algorithm
    Miri, M. S.
    Marati, V.
    Inge, L.
    Jimenez, J.
    Chen, C.
    Zuiderveld, K.
    Hayden, D.
    Lopez, B.
    Luu, D.
    Ranger-Moore, J.
    Guetter, C.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S132 - S132
  • [24] Interobserver concordance of PD-L1 clones SP263 and E1L3N in non-small cell lung carcinoma (NSCLC): two centre study
    Bozkurtlar, E.
    Karaman, D.
    Batur, S.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S51 - S52
  • [25] PREDICTORS OF PD-L1 TESTING IN NON-SMALL CELL LUNG CANCER
    DiBonaventura, M.
    Meyers, A.
    Higginbottom, K.
    Morimoto, Y.
    Ilacqua, J.
    VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
  • [26] Durvalumab for the treatment of PD-L1 non-small cell lung cancer
    Naito, Tomoyuki
    Shiraishi, Hideaki
    Fujiwara, Yutaka
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
  • [27] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [28] Current PD-L1 immunohistochemistry for non-small cell lung cancer
    Scheel, Andreas H.
    Schaefer, Stephan C.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1217 - 1219
  • [29] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [30] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
12345